These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10873032)

  • 21. High grade sarcomas are associated with microsatellite instability (chromosom 12) and loss of heterozygosity (chromosom 2).
    Rucińska M; Kozłowski L; Pepiński W; Skawrońska M; Janica J; Wojtukiewic MZ
    Med Sci Monit; 2005 Feb; 11(2):BR65-8. PubMed ID: 15668629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
    Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U
    Int J Oncol; 2004 Jul; 25(1):179-85. PubMed ID: 15202004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor.
    Tamimi Y; Ziebart K; Desaulniers N; Dietrich K; Grundy P
    Genes Chromosomes Cancer; 2007 Apr; 46(4):327-35. PubMed ID: 17243164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations on chromosome 19, 20, 21, 22, and X detected by loss of heterozygosity analysis in retinoblastoma.
    Huang Q; Choy KW; Cheung KF; Lam DS; Fu WL; Pang CP
    Mol Vis; 2003 Oct; 9():502-7. PubMed ID: 14551532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allele-specific chromosome 9p deletion in oral cancer].
    Xiao L; Ng IO; Luo ZC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):275-7. PubMed ID: 12539477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
    Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
    Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic instability in human malignant uveal melanomas].
    Proniewska-Skretek E; Pepiński W; Skawrońska M; Mariak Z; Zalewska R; Janica J; Stankiewicz A
    Klin Oczna; 2003; 105(6):401-5. PubMed ID: 15049265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distal nephron renal tumors: microsatellite allelotype.
    Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
    Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between loss of heterozygosity of chromosome 16q and survival in Wilms' tumor: A meta-analysis.
    Bu Q; He H; Fan D; Lyu J; Pan Z; You H
    Pathol Res Pract; 2018 Nov; 214(11):1772-1777. PubMed ID: 30143352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
    Yeh A; Wei M; Golub SB; Yamashiro DJ; Murty VV; Tycko B
    Genes Chromosomes Cancer; 2002 Oct; 35(2):156-63. PubMed ID: 12203779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P; Kyllönen AP; Nordling S; Vihko P
    Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
    Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
    Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.